{"id":"chlorhexidine-0-12-ethyl-alcohol-7","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Chlorhexidine's mechanism of action involves binding to the bacterial cell membrane, causing a loss of membrane integrity and ultimately leading to cell death. This results in the reduction of bacterial load and the prevention of infection.","oneSentence":"Chlorhexidine acts as a disinfectant by disrupting bacterial cell membranes, ultimately leading to cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:58.991Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Skin and soft tissue infections"},{"name":"Oral decontamination"}]},"trialDetails":[{"nctId":"NCT07490873","phase":"NA","title":"Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients","status":"RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01-05","conditions":"Effectiveness of Chlorohexidine, Effectiveness of Essential Oil, Effectiveness of Cetylpyridinium Chloride","enrollment":24},{"nctId":"NCT04149327","phase":"PHASE4","title":"Systemic Amoxicillin Plus Metronidazole in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2012-08-01","conditions":"Peri-implantitis, Periodontal Diseases","enrollment":62},{"nctId":"NCT02414581","phase":"PHASE3","title":"Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%","status":"COMPLETED","sponsor":"Hospital Regional de Alta Especialidad del Bajio","startDate":"2015-04","conditions":"Neutropenia","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"chlorhexidine 0.12%/Ethyl alcohol 7%","genericName":"chlorhexidine 0.12%/Ethyl alcohol 7%","companyName":"Hospital Regional de Alta Especialidad del Bajio","companyId":"hospital-regional-de-alta-especialidad-del-bajio","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Chlorhexidine acts as a disinfectant by disrupting bacterial cell membranes, ultimately leading to cell death. Used for Skin and soft tissue infections, Oral decontamination.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}